Annual Report, Notice of AGM & Dividend Timetable

RNS Number : 4899E
CVS Group plc
28 October 2022
 

28 October 2022

CVS Group plc

("CVS" or the "Company")

Posting of Annual Report, Notice of Annual General Meeting and Dividend Timetable

CVS, one of the UK's leading providers of integrated veterinary services, announces that its Annual General Meeting ("AGM") will be held at The Pennoyer Centre, Station Road, Pulham St Mary, IP21 4QT on 23 November 2022 at 11:00am.

The Annual Report and Accounts for the financial year ended 30 June 2022 (the "Annual Report"), the Notice of AGM and proxy form were sent on 28 October 2022 to those shareholders who have requested hard copies.  Shareholders who have elected to receive shareholder information electronically have been notified that the Annual Report and Notice of AGM are available on the Company's website at:  https://www.cvsukltd.co.uk/investor-centre , and the forms of proxy are available to shareholders on request by contacting  company.secretary@cvsvets.com .

The AGM is being held as a physical meeting.  However, the Company strongly encourages shareholders to submit a proxy vote in advance of the AGM and to appoint the Chair of the meeting as their proxy, rather than a named person who may not be able to attend the meeting if circumstances change.  Full details of voting arrangements are contained in the Notice of AGM.

As indicated in the full year results announcement on 22 September 2022, the Board is proposing a dividend of 7.0 pence per share.  Subject to shareholder approval at the AGM, the dividend will be paid on Friday, 2 December 2022 to shareholders on the register at the close of business on Friday, 18 November 2022. 

Accordingly, the ex-dividend date will be Thursday, 17 November 2022.

Contacts:

CVS Group plc                                                                                                                              via Camarco

Richard Fairman, CEO

Jenny Farrer, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)                                                                     +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

  Berenberg (Joint Broker)                                                                                              +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR) 

Geoffrey Pelham-Lane                                                                                                             +44 (0)7733 124 226

Ginny Pulbrook                                                                                                                           +44 (0)7961 315 138

  Toby Strong                                                                                                                                  +44 (0)7789 151 644  

About CVS Group plc ( www.cvsukltd.co.uk )

CVS Group is an AIM-quoted fully-integrated provider of veterinary services in the UK, with practices in the Netherlands and the Republic of Ireland. CVS is focused on providing high quality clinical services to its customers and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its three markets, including eight specialist referral hospitals and 35 dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices), Buying Groups and the Group's online retail business ("Animed Direct").

The Group employs c.8,100 personnel, including c.2,100 veterinary surgeons and c.3,000  nurses.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSBKFBDCBDKOKB

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings